Opaleye Management Inc. Portfolio Holdings

Opaleye Management Inc.

  • $548 Million
  • Q3 2024

Opaleye Management Inc. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $548 Million distributed in 44 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Harrow Health, Inc. with a value of $179M, Tg Therapeutics, Inc. with a value of $53.3M, Ocular Therapeutix, Inc with a value of $43.7M, Arvinas, Inc. with a value of $30.9M, and Codexis, Inc. with a value of $27M.

Examining the 13F form we can see an increase of $157M in the current position value, from $390M to 548M.

Opaleye Management Inc. is based out at Boston, MA

Below you can find more details about Opaleye Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $548 Million
Healthcare: $548 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$992M
$179 Million 32.75% of portfolio
3,990,000
Q2 2024 Added 1.77%
$5B
$53.3 Million 9.74% of portfolio
2,280,000
Q1 2024 Added 2.93%
$691M
$43.7 Million 7.98% of portfolio
5,025,000
Q3 2024 Reduced 5.32%
$1.01B
$30.9 Million 5.64% of portfolio
1,255,000
Q3 2024 Added 126.13%
$367M
$27 Million 4.93% of portfolio
8,770,000
Q3 2024 Added 153.84%
$3.11B
$26.2 Million 4.78% of portfolio
500,000
Q3 2024 Reduced 2.91%
$500M
$23 Million 4.19% of portfolio
395,276
Q3 2024 Added 7.56%
$145M
$18.1 Million 3.3% of portfolio
1,237,500
Q3 2024 Added 12.24%
$710M
$17 Million 3.1% of portfolio
1,698,142
Q3 2024 Added 422.51%
$322M
$16.7 Million 3.05% of portfolio
2,780,000
Q3 2024 Added 16.08%
$2.07B
$13.9 Million 2.55% of portfolio
522,500
Q3 2024 Reduced 9.91%
$52.8M
$11.2 Million 2.05% of portfolio
1,320,000
Q3 2024 Reduced 21.43%
$5.31B
$9.7 Million 1.77% of portfolio
85,000
Q1 2024 Reduced 5.56%
$981M
$9.43 Million 1.72% of portfolio
420,000
Q3 2024 Added 0.26%
$247M
$8.58 Million 1.57% of portfolio
2,567,990
Q3 2024 Reduced 2.91%
$55.2M
$6.79 Million 1.24% of portfolio
3,815,000
Q3 2024 Reduced 5.1%
$3.76B
$6.55 Million 1.2% of portfolio
64,000
Q3 2024 Added 7.93%
$257M
$5.13 Million 0.94% of portfolio
404,100
Q3 2024 Reduced 1.92%
$2.04B
$4.72 Million 0.86% of portfolio
105,000
Q2 2024 Reduced 6.83%
$4.61B
$3.98 Million 0.73% of portfolio
75,300
Q3 2024 Reduced 62.07%
$80.8M
$3.63 Million 0.66% of portfolio
3,665,010
Q3 2024 Reduced 6.27%
$177M
$3.55 Million 0.65% of portfolio
967,000
Q3 2024 New
$61.2M
$3.08 Million 0.56% of portfolio
1,681,154
Q3 2024 Reduced 27.04%
$172M
$2.26 Million 0.41% of portfolio
466,563
Q3 2024 New
$2.23B
$2.24 Million 0.41% of portfolio
112,500
Q3 2024 Reduced 82.42%
$815M
$2.07 Million 0.38% of portfolio
800,000
Q3 2024 Added 300.0%
$166M
$1.93 Million 0.35% of portfolio
1,395,000
Q3 2024 Reduced 16.47%
$89.8M
$1.56 Million 0.29% of portfolio
2,407,600
Q3 2024 Reduced 13.4%
$102M
$1.53 Million 0.28% of portfolio
179,200
Q3 2024 New
$11.2M
$1.56 Million 0.28% of portfolio
480,000
Q3 2024 Reduced 20.0%
$62.6M
$919,000 0.17% of portfolio
440,000
Q2 2024 New
$24M
$839,000 0.15% of portfolio
535,000
Q3 2024 Reduced 63.73%
$212M
$706,000 0.13% of portfolio
275,000
Q3 2024 New
Ginkgo Bioworks Holdings
-
$0 0.0% of portfolio
-
Q3 2024 New
Gossamer Bio Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Ibio Inc
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 44.85%
Cargo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.57%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 9.82%
-
$0 0.0% of portfolio
-
Q3 2024 Added 6.35%
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 19.85%
Karyopharm Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Adagio Med Hldgs Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Syros Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 24.32%

Summary

  • Portfolio
  • No. of Stocks 44
  • Current Value $548 Million
  • Prior Value $390 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 6 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 18 stocks
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email